Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension. [electronic resource]
Producer: 20190827Description: 880-893 p. digitalISSN:- 1755-3245
- Action Potentials
- Adolescent
- Adult
- Animals
- Case-Control Studies
- Disease Models, Animal
- Down-Regulation
- Female
- Humans
- Hypertension, Pulmonary -- complications
- Hypertrophy, Right Ventricular -- etiology
- Male
- Middle Aged
- Myocytes, Cardiac -- drug effects
- Nerve Tissue Proteins -- antagonists & inhibitors
- Potassium Channel Blockers -- pharmacology
- Potassium Channels, Tandem Pore Domain -- antagonists & inhibitors
- Rats
- Signal Transduction
- Sulfonamides -- pharmacology
- Time Factors
- Ventricular Dysfunction, Right -- etiology
- Ventricular Function, Right -- drug effects
- Ventricular Remodeling -- drug effects
- ortho-Aminobenzoates -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.